This discussion contains forward-looking statements that are based on current
expectations, estimates, assumptions and projections about our industry,
business and future financial results. Our actual results and the timing of
events may differ materially from those described in or implied by these
forward-looking statements due to a number of factors, including those discussed
below and those set forth under "Risk Factors" herein and other filings we make
with the SEC from time to time. Unless the context otherwise requires,
references in this "Management's Discussion and Analysis of Financial Condition
and Results of Operations" to "we", "our", "us", and "AEye" refer to the
business and operations of AEye, Inc.

Overview

AEye is a provider of high-performance, adaptive lidar systems for vehicle
autonomy, ADAS, and robotic vision applications. With a sophisticated workforce
of leaders and researchers, AEye has developed an artificial intelligence
technology that enables adaptive "intelligent sensing", differentiating AEye in
the marketplace from competition. AEye's software-definable iDAR™ ("Intelligent
Detection and Ranging") platform combines adaptive lidar, an optionally fused
camera, and integrated deterministic artificial intelligence to capture more
intelligent information with less data, enabling faster, more accurate, and more
reliable perception.

AEye was founded in 2013 by Luis Dussan, AEye's Chief Technology Officer. His
goal was to create a deterministic AI-driven sensing system that performs better
than the human eye and visual cortex. From its inception, AEye's culture drew
from esteemed scientists and electro-optics engineers from the National
Aeronautics and Space Administration ("NASA"), Lockheed Martin Corporation,
Northrop Grumman Corporation, the U.S. Air Force, and the Defense Advanced
Research Projects Agency ("DARPA") to create the highest performing sensing and
perception system for the most challenging situations, ensuring the highest
levels of safety for autonomous driving.

Our adaptive iDAR is designed to enable higher levels of autonomy and
functionality - SAE Levels 2 through 5 - with the goal of optimizing
performance, power and reducing price. Our iDAR platform is software-definable,
network-optimized, and leverages deterministic artificial intelligence at the
edge. We have substantial investments in our R&D processes and deliver value to
our customers through a combination of sales and direct channels. We perform the
majority of our R&D activities in our 56,549 square foot corporate headquarters
in Dublin, California, along with working with technology developers on a
world-wide basis to develop new technology. We are partnering with leading Tier
1 suppliers to integrate AEye proprietary technology and design, ultimately
meeting the specifications of OEMs while building reliable, trusted business
relationships.

We expect to enable accelerated adoption of lidar across many markets and have
partnered with leading Tier 1 automobile suppliers to achieve this mission. The
main markets for lidar, including Automotive, Industrial, and Mobility, are
projected to see significant growth, allowing for greater market share as well
as specialization opportunities like highway autonomous driving applications
that benefit from our product. We believe that lidar will be a required sensing
solution across many end markets and we intend to be the leading solutions
provider in this space.

All dollar amounts expressed in this Management's Discussion and Analysis of Financial Condition and Results of Operations are in thousands of dollars, except for per share amounts and unless otherwise specified.

Business Combination and Public Company Costs



As a result of the Business Combination, which was consummated on August 16,
2021, a subsidiary of CF Finance Acquisition Corp III ("CF III"), Meliora Merger
Sub, Inc., merged with and into AEye Technologies, Inc., then known as AEye,
Inc. ("AEye Technologies"), with AEye Technologies continuing as the surviving
entity as a wholly owned subsidiary of CF III, and CF III thereafter operated
under the new name AEye, Inc.

The Business Combination was accounted for as a reverse recapitalization, in
accordance with U.S. GAAP. Under this method of accounting, CF III was treated
as the legal acquirer and as the accounting acquiree. This
                                       41
--------------------------------------------------------------------------------

determination is primarily based on AEye stockholders comprising a relative
majority of the voting power of the combined entity and having the ability to
nominate the majority of the governing body of the combined entity, AEye's
senior management comprising the senior management of the combined entity and
AEye's operations comprising the ongoing operations of the combined entity.
Accordingly, for accounting purposes, the financial statements of the combined
entity will represent a continuation of the financial statements of AEye and the
Business Combination will be treated as the equivalent of AEye issuing stock for
the net assets of CF III, accompanied by a recapitalization. The most
significant change in the Company's financial position and results of the
business combination was an increase in cash of $256,811. Total non-recurring
transaction costs incurred for this transaction were $52,661.

Upon the closing of the Business Combination, the Company began trading under
the symbols "LIDR" and "LIDRW" on the Nasdaq Stock Market LLC ("Nasdaq"). We
anticipate that we will continue to hire additional personnel and implement
procedures and processes to address public company regulatory requirements and
customary practices. We have incurred and expect to incur additional annual
expenses as a public company for, among other things, directors' and officers'
liability insurance, director fees and additional internal and external
accounting and legal and administrative resources, including increased audit and
legal fees.

COVID-19 Impact

The extensive impact of the pandemic caused by the COVID-19 has resulted and
will likely continue to result in significant disruptions to the global economy,
as well as businesses and capital markets around the world. The ongoing COVID-19
pandemic has disrupted and affected AEye's business operations, which has led to
business and supply chain disruptions, as well as broad changes in its supply
and demand. For example, AEye's offices and R&D and manufacturing have been, and
from time-to-time may continue to be, impacted due to national and regional
government declarations requiring closures, quarantines and travel restrictions.

To mitigate the impact of the pandemic, AEye took several steps during 2020 to
ensure its viability into the future. We significantly reduced internal
discretionary costs, reduced senior leadership salaries, furloughed and laid off
a portion of the employees, and obtained a loan and rent deferral for a period
of six months in 2020. We also applied for and were granted a Paycheck
Protection Program, or PPP, loan of $2,270 with SVB as part of the U.S. Small
Business Administration program. This loan enabled us to bring back a portion of
the furloughed employees.

The continued impact of the COVID-19 pandemic on AEye's operational and
financial performance will depend on various future developments, including the
duration and spread of the outbreak and impact on its customers, suppliers, and
employees, all of which is uncertain at this time. We expect the COVID-19
pandemic may adversely impact our future revenue and results of operations, but
are unable to predict at this time the size and duration of this adverse impact.
At the same time, we have seen some signs of positive effects for our long-term
business prospects and partnerships as a result of the pandemic. We believe
automakers perceive the incorporation of lidar solutions in new models as a
long-term strategic initiative that will be necessary for future growth and
which are therefore beyond the direct impact of the COVID-19 pandemic. For more
information on our operations and risks related to epidemics, including
COVID-19, please see the section of this Quarterly Report on Form 10-Q entitled
"Risk Factors."

Key Factors Affecting AEye's Operating Results

AEye believes that its future performance and success depends to a substantial
extent on its ability to capitalize on the following opportunities, which in
turn is subject to significant risks and challenges, including those discussed
below and the risk factors described in the section of this Quarterly Report on
Form 10-Q entitled "Risk Factors."

We are subject to those risks common in the technology industry and also those
risks common to early stage companies including, but not limited to, the
possibility of not being able to successfully develop or commercialize its
products, attract new customers and retain existing customers, develop and
protect intellectual property, comply with existing and new or modified laws and
regulations applicable to its business, maintain and
                                       42
--------------------------------------------------------------------------------

enhance the value of its reputation and brand, hire, integrate, and retain talented people at all levels of its organization, and successfully develop new solutions to enhance the experience of customers.

Market Trends and Uncertainties

AEye anticipates growing demand for its iDAR perception platform across three
major markets, the Automotive, Industrial and Mobility markets. AEye anticipates
the total addressable market for lidar-based perception technology to grow to
$42 billion by 2030. Within those markets, AEye is targeting attractive segments
including ADAS, autonomous driving, commercial trucking, robo-taxis, and various
Industrial and Mobility market segments such as mining, aviation, shuttles,
railway, and intelligent transportation systems, or ITS. This provides AEye with
multiple opportunities for sustained growth by enabling new applications and
product features across these market segments. However, as our customers
continue R&D projects to commercialize solutions that rely on lidar technology,
it is difficult to estimate the timing of ultimate end market and customer
adoption. In the Automotive market for example, AEye's growth and financial
performance will be heavily influenced by its ability to successfully integrate
into OEM programs that require years of development, testing, and validation.
Because of the size and complexity of these OEM programs, AEye sees its existing
Tier 1 partnerships as a substantial competitive advantage given their large
scale, mass-production capabilities, and existing OEM customer relationships.
AEye's primary focus in Automotive is on ADAS for passenger and commercial
vehicle autonomy, particularly highway autonomy applications. We believe that
growth in that market is driven by both more stringent safety regulations and
consumer demand for vehicles offering increased safety. AEye will need to
anticipate and adapt to any changes in the regulatory environment, as well as
changes in consumer demand in order to take advantage of this opportunity.

Additionally, AEye is increasing its investments in international operations and
partnerships that will position the company to expand its business globally and
meet growing demand in the international markets. This is an important part of
AEye's core strategy and may expose AEye to additional factors such as foreign
currency risk, additional operating costs, and other risks and challenges that
may impact the ability to meet projected sales and margins.

Partnerships and Commercialization

AEye's technology is designed to be a key enabler of autonomous solutions for
Automotive, Industrial and Mobility applications. Because our technology must be
integrated into a broader solution by our customers, it is critical that AEye
achieves design wins with these customers. Achieving these design wins varies
based on the market and application. The design win cycle in the Automotive
market tends to be substantially longer and more difficult than in other
markets. Achieving a design win with an OEM within the Automotive market may
take considerably longer than a design win with customers in the Industrial or
Mobility markets. AEye considers design wins to be critical to its future
success, although the revenue generated by each design win and the time
necessary to achieve such a win can vary significantly, making it difficult to
predict AEye's financial performance.

AEye's revenue and profitability will be dependent upon our success in licensing
our technology to Tier 1 automotive suppliers, such as Continental, that intend
to use our technology in volume production of lidar sensors for OEMs. Delays of
autonomy programs from OEMs that AEye is currently or will be working with
through our Tier 1 partners could result in AEye being unable to achieve its
revenue targets and profitability in the time frame we anticipate. Our revenue
and profitability will be further dependent upon both our success in selling our
lidar solutions to customers in the Industrial and Mobility markets.

Gross Margin Improvement



Our gross margins will depend on numerous factors, including among others the
average selling price of our products, pricing of our development contracts with
customers, royalty rates on licenses we grant to our customers, unit volumes,
product mix, component costs, personnel costs, contract manufacturing costs,
overhead costs, and product features. In the future, we expect to generate
attractive gross margins from licensing our lidar technology and software to our
Tier 1 partners in Automotive, and we expect those licenses will begin
generating revenue for AEye in 2024. We also sell our own lidar solutions to
customers in the Industrial and Mobility markets
                                       43
--------------------------------------------------------------------------------

utilizing low-cost components that are sourced from the Tier 2 automotive supply
chain and assembled by our contract manufacturing partners. If our Tier 1
partners in Automotive do not achieve the volumes that we expect, then the cost
of the components we use to address the Industrial and Mobility markets may be
higher than we currently anticipate and may impact our gross margins and our
ability to achieve profitability.

To date, our revenue has been generated through development and/or collaboration
arrangements with OEMs and Tier 1 suppliers to the OEMs, as well as unit sales
of our products. The development contracts primarily focus on customization of
our proprietary iDAR capabilities to the customers' applications, typically
involving software implementation to assist with sensor connection and control,
customization of scan patterns, and enhancement of particular perception
capabilities to meet specific customer needs. In general, development and/or
collaboration arrangements that require more complex configurations have higher
prices and higher gross margins. We expect development contracts to represent a
smaller share of our total revenue over time, as we increase our focus on
technology licensing and product sales. We expect our gross margins from the
sale of products to improve over time as we outsource volume production of our
lidar sensors to contract manufacturers, which will both increase unit volumes
and reduce the cost per unit. In September 2021, we commenced our transition
process to contract manufacturers.

Investment and Innovation



Our proprietary adaptive, intelligent lidar technology delivers industry-leading
performance that helps to solve the most difficult challenges in delivering
partial or full autonomy. While traditional sensing systems passively collect
data, AEye's active iDAR leverages principles from automated targeting systems
and biomimicry to scan its environment, while intelligently focusing on what
matters in order to enable safer, smarter, and faster decisions in complex
scenarios.

We believe our financial performance is significantly dependent on our ability
to maintain a technology leadership position. This is further dependent on the
investments we make in R&D. It is essential that we continually identify and
respond to rapidly evolving customer requirements, develop and introduce
innovative new products, enhance and service existing products, and generate
strong market demand for our products. If we fail to do this, our leading market
position and revenue may be adversely affected, and our investments in that area
will not be recovered.

Components of Results of Operations

Total Revenues



We categorize our revenue as (1) prototype sales and (2) development contracts.
In 2020 and during the first three quarters of 2021, our prototype revenue
primarily related to unit sales of the company's 4Sight M product. Revenue from
prototype sales is typically recognized at a point in time when the control of
goods is transferred to the customer, generally upon delivery or shipment to the
customer.

Development contracts represented the majority of our total revenues in 2020 and
approximately half of total revenues for the first three quarters of 2021.
Revenue from development contracts are earned from R&D and/or collaboration
arrangements with OEMs and Tier 1 suppliers to the OEMs. These contracts
primarily focus on customization of our proprietary iDAR capabilities to the
customers' applications, typically involving software implementation to assist
with sensor connection and control, customization of scan patterns, and
enhancement of perception capabilities to meet specific customer needs. Revenue
from development contracts is recognized when we satisfy performance obligations
in the contract, which can result in recognition at either a point in time or
over time. This assessment is made at the outset of the arrangement for each
performance obligation.


Cost of Revenue



Cost of Revenue includes the cost of component inventory used in the production
of prototypes, direct and indirect labor costs associated with the units, as
well as direct labor associated with development contracts.
                                       44
--------------------------------------------------------------------------------



Operating Expenses

Research and Development

Our R&D efforts are focused primarily on hardware, software, and system engineering related to the design and development of our advanced lidar solutions. R&D expenses include:



•personnel-related expenses, including salaries, benefits, bonuses, and
stock-based compensation expense;
•third-party engineering and contractor costs;
•new hardware and software expenses; and
•allocated overhead expenses.

R&D costs are expensed as they are incurred. Our investment in R&D will continue
to grow because we believe that investment is essential to maintain our position
as a provider of one of the most advanced lidar solutions available.

Sales and Marketing



Our sales and marketing expenses consist primarily of personnel-related costs,
including salaries, benefits, bonuses, and stock-based compensation, for all
personnel directly involved in business development and customer account
management, trade shows expenses, advertising and promotions expenses for press
releases, other public relations services, and allocated overhead expenses. We
expect our sales and marketing expense to grow over time as we continue to
expand our sales and marketing efforts to support the anticipated growth of our
business.

General and Administrative

Our general and administrative expenses consist primarily of personnel-related
costs, including salaries, benefits, bonuses, and stock-based compensation, for
executive, finance, legal, human resources, technical support, and other
administrative personnel. Other significant expenses include consulting,
accounting, legal and professional fees, insurance premiums, software and
computer equipment costs, general office expenses, and allocated overhead
expenses. We expect our general and administrative expenses to increase for the
foreseeable future as we increase our headcount to support the growth of our
business, and as a result of operating as a public company, including additional
costs and expenses associated with compliance with the rules and regulations of
the SEC, legal, audit, insurance, investor relations, and other administrative
and professional services.

Change in Fair Value of Embedded Derivative and Warrant Liabilities



Change in fair value of embedded derivative and warrant liabilities is the
result of the change in fair value at each reporting date. The carrying amounts
of the embedded derivative and warrant liabilities are recorded at fair value at
issuance, marked-to-market as of each balance sheet date, and changes in fair
value are reported as either income or expense during the period. Upon the
closing of the Business Combination, the embedded derivative was settled, the
pre-combination common stock warrants and Series A preferred stock warrants were
net settled and converted to Class A common stock and private placement warrants
were acquired as part of the Business Combination.

Interest Income, Interest Expense and Other



Interest income consists primarily of interest earned on our cash, cash
equivalents and marketable securities. These amounts will vary based on our cash
and cash equivalents balances and market rates. Interest expense consisted
primarily of interest on our borrowings and convertible notes and amortization
of debt issuance costs and discount.

Results of Operations


                                       45
--------------------------------------------------------------------------------

Comparison of the Three Months Ended September 30, 2021 and 2020



The results of operations presented below should be reviewed in conjunction with
the condensed consolidated financial statements and notes included elsewhere in
this report. The following table sets forth our condensed consolidated results
of operations data for the three months ended September 30, 2021 and 2020 (in
thousands, except for percentages):

                                      Three months ended September 30,            Change                  Change
                                          2021                 2020                  $                       %

Prototype sales                      $        127          $       87          $       40                        46.0  %
Development contracts                           -               1,050              (1,050)                     (100.0) %
Total revenues                                127               1,137              (1,010)                      (88.8) %
Cost of revenue                               466                 317                 149                        47.0  %
Gross (loss) profit                          (339)                820              (1,159)                     (141.3) %
Research and development                    7,468               3,247               4,221                       130.0  %
Sales and marketing                         2,991                 672               2,319                       345.1  %
General and administrative                  6,086               1,650               4,436                       268.8  %
Total operating expenses                   16,545               5,569              10,976                       197.1  %
Loss from operations                      (16,884)             (4,749)            (12,135)                      255.5  %
Change in fair value of embedded
derivative and warrants liabilities           341               1,366              (1,025)                      (75.0) %
Gain on PPP loan forgiveness                    -                   -                   -                         0.0  %
Interest income and other                      69                   6                  63                     1,050.0  %
Interest expense and other                   (919)               (401)               (518)                      129.2  %
Total other income (expense), net            (509)                971              (1,480)                     (152.4) %
Net loss                             $    (17,393)         $   (3,778)         $  (13,615)                      360.4  %


Revenue

Prototype Sales

Prototype sales increased by $40, or 46.0%, for the three months ended September 30, 2021. This increase was primarily due to an increase in 4Sight M unit sales.



Development Contracts

Development contracts decreased by $1,050 or 100.0%, for the three months ended
September 30, 2021. The decrease was primarily due to revenue recognized in the
prior year from a large Tier 1 contract.




Cost of Revenue

Cost of revenue increased by $149, or 47.0%, for the three months ended September 30, 2021. This increase was primarily due to inventory adjustments, offset by less units shipped in the current quarter.


                                       46
--------------------------------------------------------------------------------



Operating Expenses

Research and Development

Research and development expenses increased by $4,221, or 130.0%, for the three
months ended September 30, 2021. This increase was primarily driven by an
increase in nonrecurring engineering research and development fees of $2,547,
stock-based compensation expense of $571, personnel costs of $861, and
administrative expenses of $312, including IT charges of $272.

Sales and Marketing



Total sales and marketing expenses increased by $2,319, or 345.1%, for the three
months ended September 30, 2021. This increase was primarily due to an increase
in marketing program spend of $664, stock-based compensation expense of $362,
and personnel costs of $1,080.

General and Administrative



Total general and administrative expenses increased by $4,436, or 268.8%, for
the three months ended September 30, 2021. This increase was primarily due to an
increase in administrative fees of $2,194, including insurance fees of $636,
professional fees of $1,177, and personnel costs of $1,400.

Change in Fair Value of Embedded Derivative and Warrant Liabilities



Change in fair value of embedded derivative and warrant liabilities decreased
$1,025, or 75.0% for the three months ended September 30, 2021. This decrease
was primarily due to a significant decrease in the fair value of the embedded
derivative resulting in a gain during Q3 2020.

Gain on PPP Loan Forgiveness

Gain on PPP loan forgiveness had a $0 balance for the three months ended September 30, 2021 and 2020.

Interest Income and Other



Interest income and other increased by $63, or 1,050.0%, for the three months
ended September 30, 2021. This increase was primarily due to the interest earned
on our marketable securities of $65 in September 2021.

Interest Expense and Other



Interest expense and other increased by $518, or 129.2%, for the three months
ended September 30, 2021. This increase was primarily due to the expense
increase related to the SVB financing facility loan of $111, an increase in
interest on convertible notes of $49, and an increase in the amortization of
debt discount and issuance costs of $257.

Net Loss

Net loss increased by $13,615, or 360.4%, for the three months ended September 30, 2021. This increase was primarily due an increase in the operating expenses.

Comparison of the Nine Months Ended September 30, 2021 and 2020



The results of operations presented below should be reviewed in conjunction with
the condensed consolidated financial statements and notes included elsewhere in
this report. The following table sets forth our
                                       47
--------------------------------------------------------------------------------

condensed consolidated results of operations data for the nine months ended September 30, 2021 and 2020 (in thousands, except for percentages):



                                         Nine months ended September 30,              Change                  Change
                                            2021                   2020                  $                      %

Prototype sales                      $            588          $      150          $      438                      292.0  %
Development contracts                             615               1,150                (535)                     (46.5) %
Total revenues                                  1,203               1,300                 (97)                      (7.5) %
Cost of revenue                                 1,537                 464               1,073                      231.3  %
Gross (loss) profit                              (334)                836              (1,170)                    (140.0) %
Research and development                       19,030              11,207               7,823                       69.8  %
Sales and marketing                             6,489               2,610               3,879                      148.6  %
General and administrative                     13,846               4,862               8,984                      184.8  %
Total operating expenses                       39,365              18,679              20,686                      110.7  %
Loss from operations                          (39,699)            (17,843)            (21,856)                     122.5  %
Change in fair value of embedded
derivative and warrant liabilities                222               1,284              (1,062)                     (82.7) %
Gain on PPP loan forgiveness                    2,297                   -               2,297                      100.0  %
Interest income and other                          74                  19                  55                      289.5  %
Interest expense and other                     (2,871)               (955)             (1,916)                     200.6  %
Total other income (expense), net                (278)                348                (626)                    (179.9) %
Net loss                             $        (39,977)         $  (17,495)         $  (22,482)                     128.5  %



Revenue

Prototype Sales

Prototype sales increased by $438, or 292.0%, for the nine months ended September 30, 2021. This increase was primarily due to an increase in 4Sight M unit sales.



Development Contracts

Development contracts decreased by $535, or 46.5%, for the nine months ended
September 30, 2021. The decrease was primarily due to revenue recognized in the
prior year from a large Tier 1 contract.

Cost of Revenue

Cost of revenue increased by $1,073, or 231.3%, for the nine months ended September 30, 2021. This increase was primarily due to increased sales as well as price variances and inventory adjustments.

Operating Expenses

Research and Development



Research and development expenses increased by $7,823, or 69.8%, for the nine
months ended September 30, 2021. This increase was primarily driven by an
increase in nonrecurring engineering research and development fees of $4,910,
stock-based compensation expense of $1,721, personnel costs of $901, and
administrative expenses of $481, including IT charges of $460.
                                       48
--------------------------------------------------------------------------------

Sales and Marketing



Total sales and marketing expenses increased by $3,879, or 148.6%, for the nine
months ended September 30, 2021. This increase was primarily due to an increase
in marketing program spend of $924, stock-based compensation expense of $1,055,
and personnel costs of $1,702.

General and Administrative



Total general and administrative expenses increased by $8,984, or 184.8%, for
the nine months ended September 30, 2021. This increase was primarily due to an
increase in administrative expense, including professional accounting and legal
fees of $2,371, stock-based compensation expense of $2,930, and personnel costs
of $2,634.

Change in Fair Value of Embedded Derivative and Warrant Liabilities



Change in fair value of embedded derivative and warrant liabilities decreased by
$1,062 or 82.7% for the nine months ended September 30, 2021. This decrease was
due to a significant decrease in the fair value of the embedded derivative
resulting in a gain during Q3 2020.

Gain on PPP Loan Forgiveness



Gain on PPP loan forgiveness increased by $2,297, or 100.0% for the nine months
ended September 30, 2021. This increase was due to the gain from the forgiveness
of the PPP loan.

Interest Income and Other

Interest income and other increased by $55, or 289.5%, for the nine months ended
September 30, 2021. This increase was primarily due to the interest earned on
our marketable securities of $65 in September 2021.

Interest Expense and Other



Interest expense and other increased by $1,916, or 200.6%, for the nine months
ended September 30, 2021. This increase was primarily due to the expense
increase related to the SVB financing facility loan of $235, interest on
convertible notes of $510 and an increase in the amortization of debt discount
and issuance costs of $923.

Net Loss

Net loss increased by $22,482, or 128.5%, for the nine months ended September 30, 2021. This increase was primarily due to an increase in operating expenses.

Liquidity and Capital Resources

Sources of Liquidity

AEye's capital requirements will depend on many factors, including sales volume,
the timing and extent of spending to support R&D efforts, investments in
information technology systems, the expansion of sales and marketing activities,
increased costs as we continue to hire additional personnel, and market adoption
of new and enhanced products and features. As of September 30, 2021, our cash,
cash equivalents, and marketable securities totaled $182,378.

To date, AEye's principal sources of liquidity have been proceeds received from
the issuance of equity. Until AEye can generate sufficient revenue from the sale
of its products to cover operating expenses, working capital, and capital
expenditures, AEye expects the funds raised in the Business Combination,
including the funds
                                       49
--------------------------------------------------------------------------------

from PIPE financing, to fund its cash needs. If we are required to raise
additional funds by issuing equity securities, dilution of stockholders may
result. Any debt securities issued may also have rights, preferences, and
privileges senior to those of holders of AEye common stock. The terms of debt
securities or borrowings could impose significant restrictions on AEye's
operations. The credit market and financial services industry have in the past,
and may in the future, experience periods of uncertainty that could impact the
availability and cost of equity and debt financing.

During the nine months ended September 30, 2021 and 2020, we had a net loss of
$39,977 and $17,495, respectively. We anticipate that we will continue to incur
losses for at least the next several years. We expect that our research and
development expenses and selling, general and administrative expenses will
continue to be significant and, as a result, we may need additional capital
resources to fund our operations. We believe that the net proceeds from the
Business Combination, together with our existing cash, cash equivalents and
marketable securities will enable us to fund our operating expenses and capital
expenditure requirements for a period of at least twelve months from the date of
this Quarterly Report on Form 10-Q.

Cash Flow Summary

                                           Nine months ended September 30,
                                                 2021                     2020
                                                    (in thousands)
Net cash provided by (used in):
Operating activities                $         (39,588)                 $ (13,958)
Investing activities                $        (130,712)                 $  (4,017)
Financing activities                $         208,421                  $  14,428



Operating Activities

For the nine months ended September 30, 2021, net cash used in operating
activities was $39,588. Factors affecting our operating cash flows during this
period were net loss of $39,977 and gain on PPP loan forgiveness of $2,297,
offset by stock-based compensation of $6,522, amortization of issuance costs of
$725, and amortization of debt issuance costs of $752. Within operating
activities, the net changes in operating assets and liabilities was cash used of
$6,193, primarily driven by increases in prepaids and other current assets of
$5,305 and inventory of $2,197, partially offset by increases in accrued
expenses and other current liabilities of $1,417, and accounts payable of $840.

For the nine months ended September 30, 2020, net cash used in operating
activities was $13,958. Factors affecting our operating cash flows during this
period were net loss of $17,495 and change in fair value of embedded derivative
and liability of $1,284, offset by stock-based compensation of $815 and
depreciation and amortization of $679. Within operating activities net changes
in operating assets and liabilities was cash provided of $2,657, primarily
driven by decreases in prepaids and other current assets of $3,832, partially
offset by increases in inventory of $414.

Investing Activities



For nine months ended September 30, 2021, net cash used in investing activities
was $130,712. The primary factor affecting net cash used in investing activities
during this period was the purchase of available-for-sale securities of
$129,999.

For nine months ended September 30, 2020, net cash used in investing activities
was $4,017, due to the purchase of property and equipment of $4,017 associated
with the construction allowance for the new headquarters.

Financing Activities


                                       50
--------------------------------------------------------------------------------

For the nine months ended September 30, 2021, net cash provided by financing
activities was $208,421. The primary factors affecting our financing cash flows
during this period were the proceeds from the Business Combination and private
offering of $256,811, partially offset by transaction costs related to the
Business Combination of $47,775, proceeds from a bank loan of $10,000, offset by
principal payments on the credit facility of $13,333.

For the nine months ended September 30, 2020, net cash provided by financing
activities was $14,428. The primary factors affecting our financing cash flows
during this period were the proceeds from the issuance of AEye Convertible
Equity Instruments of $12,596, proceeds from PPP loan of $2,270, offset by
principal payments on a credit facility of $444.

Contractual Obligations and Commitments



In the normal course of business, we enter into obligations and commitments that
require future contractual payments. The commitments result primarily from lease
for office space. The following table summarizes our contractual obligations and
commercial commitments (in thousands) as of September 30, 2021:

                   Less than                                              More than
                     1 year         1 to 3 years       3 to 5 years        5 years
Rental Payments   $     2,333      $       4,719      $       5,006      $      425
Total             $     2,333      $       4,719      $       5,006      $      425

Off-Balance Sheet Arrangements



As of the balance sheet date of September 30, 2021 we have not engaged in any
off-balance sheet arrangements, as defined in the rules and regulations of the
SEC.

Critical Accounting Policies and Estimates



Our condensed consolidated financial statements are in accordance with GAAP. We
are required to make estimates and assumptions that affect the reported amounts
of assets and liabilities as of the date of the condensed consolidated financial
statements, the reported amounts of revenues and expenses during the reporting
periods, fair value measures and the related disclosures in the condensed
consolidated financial statements. We base our estimates on historical
experience and on various other assumptions that we believe are reasonable under
the circumstances. The results of our analysis form the basis for making
assumptions about the carrying values of assets and liabilities and fair value
measures that are not readily apparent from other sources. As a result, these
accounting policies could materially affect our financial statements.

Revenue



We recognize revenues from the sale of prototype systems and from R&D and
collaboration and development arrangements with OEMs and suppliers to the OEMs.
Revenue represents the amount of expected consideration we are entitled to
receive upon the transfer of promised goods or services in the ordinary course
of our activities and is recorded net of sales taxes. We recognize revenue when
performance obligations are satisfied by transferring control of a promised good
or service to a customer. For performance obligations that are satisfied at a
point in time, we also consider the following indicators to assess whether
control of a promised good or service is transferred to the customer: (i) right
to payment; (ii) legal title; (iii) physical possession; (iv) significant risks
and rewards of ownership; and (v) acceptance of the good or service. For
performance obligations satisfied over time, we recognize revenue over time by
measuring the progress toward complete satisfaction of a performance obligation.

The application of various accounting principles related to the measurement and recognition of revenue requires us to make judgments and estimates. Specifically, complex arrangements with nonstandard terms and


                                       51
--------------------------------------------------------------------------------

conditions may require relevant contract interpretation to determine the
appropriate accounting treatment, including whether the promised goods and
services specified in a multiple element arrangement should be treated as
separate performance obligations. When a contract involves multiple performance
obligations, the Company accounts for individual products and services
separately if the customer can benefit from the product or service on its own or
with other resources that are readily available to the customer and the product
or service is separately identifiable from other promises in the arrangement.
For multiple element obligations, the transaction price is allocated to each
performance obligation using the relative stand-alone selling price.

Stock-Based Compensation



We recognize stock-based awards granted to our employees and directors based on
the estimated grant-date fair value of the awards. Compensation expense is
recognized on a straight-line basis over the requisite service period, which is
generally the vesting period of the respective award. We estimate the fair value
of options using the Black-Scholes option-pricing model, which requires
objective and subjective assumptions such as the option's expected term, fair
value of our ordinary shares, risk-free interest rate, expected dividend yield,
expected term, and expected volatility of our ordinary shares. Our assumptions
may differ from those used in prior periods. Changes to the estimates we make
from time to time may have a significant impact on our stock-based compensation
expense and could materially impact our results of operations.

The grant date fair value of our common stock, prior to the closing of the
Business Combination was determined using valuation methodologies that utilize
certain assumptions, including probability weighting of events, volatility, time
to liquidation, a risk-free interest rate, and an assumption for a discount for
lack of marketability. Subsequent to the closing of the Business Combination the
valuation of our common stock was determined using the publicly traded closing
price as reported on Nasdaq.

Emerging Growth Company Status



Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 ("JOBS
Act") exempts emerging growth companies from being required to comply with new
or revised financial accounting standards until private companies are required
to comply with the new or revised financial accounting standards. The JOBS Act
provides that a company can choose not to take advantage of the extended
transition period and comply with the requirements that apply to non-emerging
growth companies, and any such election to not take advantage of the extended
transition period is irrevocable.

AEye is an "emerging growth company" as defined in Section 2(a) of the
Securities Act, and has elected to take advantage of the benefits of the
extended transition period for new or revised financial accounting standards.
Following the consummation of the Business Combination, our Post-Combination
Company will remain an emerging growth company until the earliest of (i) the
last day of the fiscal year in which the market value of common stock that is
held by non-affiliates exceeds $700 million as of the end of that year's second
fiscal quarter, (ii) the last day of the fiscal year in which the Company has
total annual gross revenue of $1.07 billion or more during such fiscal year (as
indexed for inflation), (iii) the date on which the Company has issued more than
$1.0 billion in non-convertible debt in the prior three-year period, or (iv)
December 31, 2024. AEye expects to continue to take advantage of the benefits of
the extended transition period, although it may decide to early adopt such new
or revised accounting standards to the extent permitted by such standards. This
may make it difficult or impossible to compare the Company's financial results
with the financial results of another public company that is either not an
emerging growth company or is an emerging growth company that has chosen not to
take advantage of the extended transition period exemptions because of the
potential differences in accounting standards used.





Recent Accounting Pronouncements


                                       52

--------------------------------------------------------------------------------



See Note 1 to AEye's financial statements included elsewhere in this Quarterly
Report on Form 10-Q for recently adopted accounting pronouncements and recently
issued accounting pronouncements not yet adopted as of the date of this
Quarterly Report on Form 10-Q.

© Edgar Online, source Glimpses